19 / 148
Informaciones
Psiquiátricas
2018 - n.º
232
19
model of dynamic biomarkers of the
Alzheimer's pathological cascade. Lan-
cet Neurol 2010; 9:119-128.
12. McKhann G, Drachman D, Folstein M,
et al. Clinical diagnosis of Alzheimer’s
disease: report of the NINCDS-ADRDA
Work Group under the auspices of De-
partment of Health and Human Services
Task Force on Alzheimer’s Disease. Neu-
rology 1984; 34:939-944.
13. McKhann GM, Knopman DS, Chertkow
H, et al.The diagnosis of dementia due
to Alzheimer's disease: recommenda-
tions from the National Institute on
Aging-Alzheimer's Association work-
groups on diagnostic guidelines for
Alzheimer's disease.Alzheimers Dement.
2011;7(3):263-9.
14. Molinuevo JL, Blennow K, Dubois B,
et al. The clinical use of cerebrospinal
fluid biomarker testing for Alzheimer's
disease diagnosis: a consensus paper
from the Alzheimer's Biomarkers Stan-
dardization Initiative. Alzheimers De-
ment. 2014 Nov;10(6):808-17.
15. Morris JC, Roe CM, Xiong C, Fagan
AM, Goate AM, Holtzman DM, Min-
tun MA.APOE predicts amyloid-beta
but not tau Alzheimer pathology in
cognitively normal aging.Ann Neurol.
2010;67(1):122-31.
16. Olsson B, Lautner R, Andreasson U,et
al.CSF and blood biomarkers for the
diagnosis of Alzheimer's disease: a sys-
tematic review and meta-analysis. Lan-
cet Neurol. 2016 Jun;15(7):673-84.
17. Shaw LM, Vanderstichele H, Knapik-Cza-
jka M, et al; Alzheimer's Disease Neu-
roimaging Initiative.Cerebrospinal fluid
biomarker signature in Alzheimer's di-
sease neuroimaging initiative subjects.
Ann Neurol. 2009; 65(4):403-13
18. Sperling RA, Aisen PS, Beckett LA, et
al.Toward defining the preclinical sta-
ges of Alzheimer's disease: recommen-
dations from the National Institute on
Aging-Alzheimer's Association work-
groups on diagnostic guidelines for
Alzheimer's disease. Alzheimers De-
ment. 2011;7(3):280-92.
19. Tapiola T, Alafuzoff I, Herukka SK, et al.
Cerebrospinal fluid {beta}-amyloid 42
and tau proteins as biomarkers of Al-
zheimer-type pathologic changes in the
brain.Arch Neurol. 2009; 66(3):382-9.
20. Vanderstichele H, Bibl M, Engelborghs
S, et al. Standardization of preanalyti-
cal aspects of cerebrospinal fluid bio-
marker testing for Alzheimer's disease
diagnosis: A consensus paper from the
Alzheimer's Biomarkers Standardization
Initiative.Alzheimers Dement. 2011 Oct
31. 2012 Jan;8(1):65-73.
BIOMARCADORES DE LÍQUIDO CEFALORRAQUÍDEO EN LA ENFERMEDAD DE ALZHEIMER